conference XXXX fourth you joining thank for and call. afternoon, our quarter Good
During my going insight CEO, into my to quarter. highlights provide during strategic Inogen. today's priorities and pleased call, here forward, a recent experiences my call as few months I'm our leading the be first share I first earnings will at outline from
great We have product great and team a portfolio. a
month roots. challenges as the global field I organization our substantial and internal business, my observed structure, external performance. and reflected of management our its sales visiting from first to on I our spent strengths CEO, portfolio, understand have have investors my time the within During and much feedback regarding and strategy, and teams, seeking company
have opportunity across conversations our company immense I the business. From to the confidence ahead capability my in leaders, improvements with of our and the make
to strategize additional X our path leaders pleased to forward, our I As welcome team. I'm new
Greg as and products, improve are experience. Chief strategy Ramade to will We thrilled commercial have in experience Inogen's Commercial help Greg's January. appointed Officer customer
their additions Michael bringing teams. potential. strengthening also FP&A our Michael We January. the both our as late are X, Bourque finance in stewarding appointment March confident new company forward Inogen's of to will that step accounting joining am achieving next look week, CFO, announced effective and I full and whose on organization towards our a we be
I would into Inogen's like to strategic forward. priorities share going insights
remain the to updates of as our lives be for patients. expand for and about exciting and opportunity we'll our Our this an ability to our pursuit increasing represents An to impact they're optimistic is achieve We of process growth. Physio-Assist the Physio-Assist existing portfolio, top new market. is regulatory piece revenue U.S. positioning important of priority providing available. the clearance, the ability clearance business to introduction
this make and We cost to also our a with This portfolio. advancing pipeline optimization improve our products and includes we innovation innovation with end, coming mobile of the Advancing is health will our technologies profitability also of the pursuing transformative within priority. production evaluating be our accessible, to the a digital to sold. in sustainable more structures To goods cost return intent development key are effective. years. We're
new Inogen cost further diagnostic establishing ease we markets. can And superior business-to-business in patient devices us our best-in-class to evaluate will that and and of proviral continued all and strengthen sales stakeholders the loyalty. platforms to improve In efforts, relationships market, investment known their with compliance, distributors patient capabilities. tandem use our these and further our effectiveness continue know our bring to strategies are preference Inogen monitoring and for and in even existing with of their and with take partners POCs
most highest to therapies the remain respiratory to We quality, the patients dedicated around dependable advanced most and delivering globe.
to Now quarter total We accomplishments fiscal the $XXX in XXXX and revenue. achieved I fourth revenue quarter $XX full our highlight XXXX. million in during and fourth like million would year year
recent Our launch our well along with part which in full the by in were Rove X sales driven progressing is of Europe, expectations.
We several have XXXX. followed of XXXX our achievements early progress areas in with
and conclusion compelling therapy of Baseline period mobile evidence POCs of higher lower through the real-world oxygen mortality health illness using the a utilization median The ER patients. resource visits costs analyzed using supporting POCs patients XX-month completed POCs recently For cost longer in study burden effectiveness, was autonomy. months patients duration overall survival, to duration risks strongly with shorter and X lower and correlated of over of care and study. example, risk saw long-term with XXX,XXX adoption a of a mobility over of we autonomy of than hospitalizations lower consequently,
benefits. we using devices patients. our is key are in with At restrict that their reinforces not to patient well-being that pride further This it Inogen, mobility have offer health take the do and and compatible the in devices mobility it clear
and to battery improve mobility always weight to are outcomes. improve through ways patient life, find to device striving We size
rolled partners. sure for our specific to to our to for out maintenance to ability patient linked Inogen updates also practical connect connected devices, of are wearable app early experiences February, devices. but to and we ability for monitoring all portals and devices dependable, notifications These not track only service make are error minute, changes part per users. included In to patient better effort and and breaths the business-to-business and Changes customers diagnostic user our provide broader
initiated have a we via [ run our our in channel list ] which we prescribe addition, within referrals. POCs In shift
to of we to and in-house. patients an As effort increase our moving process, bringing forecasting as away rentals we as from is step partnerships improve are able support ensuring predictability, and possible. the the of rental this external channel our continued and many important for are expand rental prescriber part sales I assist believe one our
evaluate opportunities structure. we to always, for all As of streamline will our business to cost and look continue relationships our
the to the a market. business-to-business of seeing over to turn I in opportunity market capitalize address I'd we recent also domestic our brand differentiated the exiting this the news competitor call Before to but the leadership, on we to Due are development, like product recognition. volatility potential see offering channel, Mike, some and
we be void to it. if there market, be so, will expect We in the may step and fill in a and that ready
review financial I'll now Mike? turn the call more over of to a our Mike results. detailed for